Literature DB >> 27644128

Glucocorticoid Administration Improves Aberrant Fear-Processing Networks in Spider Phobia.

Masahito Nakataki1,2, Leila M Soravia1, Simon Schwab1, Helge Horn1, Thomas Dierks1, Werner Strik1, Roland Wiest3,4, Markus Heinrichs5,6, Dominique J-F de Quervain7, Andrea Federspiel1, Yosuke Morishima1,8.   

Abstract

Glucocorticoids reduce phobic fear in patients with anxiety disorders. Previous studies have shown that fear-related activation of the amygdala can be mediated through the visual cortical pathway, which includes the fusiform gyrus, or through other pathways. However, it is not clear which of the pathways that activate the amygdala is responsible for the pathophysiology of a specific phobia and how glucocorticoid treatment alleviates fear processing in these neural networks. We recorded the brain activity with functional magnetic resonance imaging in patients with spider phobia, who received either 20 mg of cortisol or a placebo while viewing pictures of spiders. We also tested healthy participants who did not receive any medication during the same task. We performed dynamic causal modelling (DCM), a connectivity analysis, to examine the effects of cortisol on the networks involved in processing fear and to examine if there was an association between these networks and the symptoms of the phobia. Cortisol administration suppressed the phobic stimuli-related amygdala activity to levels comparable to the healthy participants and reduced subjective phobic fear. The DCM analysis revealed that cortisol administration suppressed the aberrant inputs into the amygdala that did not originate from the visual cortical pathway, but rather from a fast subcortical pathway mediated by the pulvinar nucleus, and suppressed the interactions between the amygdala and fusiform gyrus. This network changes were distinguishable from healthy participants and considered the residual changes under cortisol administration. We also found that the strengths of the aberrant inputs into the amygdala were positively correlated with the severity of spider phobia. This study demonstrates that patients with spider phobia show an aberrant functional connectivity of the amygdala when they are exposed to phobia-related stimuli and that cortisol administration can alleviate this fear-specific neural connectivity.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27644128      PMCID: PMC5399241          DOI: 10.1038/npp.2016.207

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  53 in total

1.  Resolving emotional conflict: a role for the rostral anterior cingulate cortex in modulating activity in the amygdala.

Authors:  Amit Etkin; Tobias Egner; Daniel M Peraza; Eric R Kandel; Joy Hirsch
Journal:  Neuron       Date:  2006-09-21       Impact factor: 17.173

2.  Neural dynamics for facial threat processing as revealed by gamma band synchronization using MEG.

Authors:  Qian Luo; Tom Holroyd; Matthew Jones; Talma Hendler; James Blair
Journal:  Neuroimage       Date:  2006-11-13       Impact factor: 6.556

3.  Dynamic causal modelling.

Authors:  K J Friston; L Harrison; W Penny
Journal:  Neuroimage       Date:  2003-08       Impact factor: 6.556

4.  A subcortical pathway to the right amygdala mediating "unseen" fear.

Authors:  J S Morris; A Ohman; R J Dolan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

5.  Brain dynamics of visual attention during anticipation and encoding of threat- and safe-cues in spider-phobic individuals.

Authors:  Jaroslaw M Michalowski; Christiane A Pané-Farré; Andreas Löw; Alfons O Hamm
Journal:  Soc Cogn Affect Neurosci       Date:  2015-01-20       Impact factor: 3.436

6.  Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis.

Authors:  C Kirschbaum; B M Kudielka; J Gaab; N C Schommer; D H Hellhammer
Journal:  Psychosom Med       Date:  1999 Mar-Apr       Impact factor: 4.312

7.  Glucocorticoids reduce phobic fear in humans.

Authors:  Leila M Soravia; Markus Heinrichs; Amanda Aerni; Caroline Maroni; Gustav Schelling; Ulrike Ehlert; Benno Roozendaal; Dominique J-F de Quervain
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

8.  Fear of Spiders Questionnaire.

Authors:  J Szymanski; W O'Donohue
Journal:  J Behav Ther Exp Psychiatry       Date:  1995-03

Review 9.  On the unconscious subcortical origin of human fear.

Authors:  Arne Ohman; Katrina Carlsson; Daniel Lundqvist; Martin Ingvar
Journal:  Physiol Behav       Date:  2007-05-25

10.  Low-dose cortisol for symptoms of posttraumatic stress disorder.

Authors:  Amanda Aerni; Rafael Traber; Christoph Hock; Benno Roozendaal; Gustav Schelling; Andreas Papassotiropoulos; Roger M Nitsch; Ulrich Schnyder; Dominique J-F de Quervain
Journal:  Am J Psychiatry       Date:  2004-08       Impact factor: 18.112

View more
  6 in total

Review 1.  The influence of subcortical shortcuts on disordered sensory and cognitive processing.

Authors:  Jessica McFadyen; Raymond J Dolan; Marta I Garrido
Journal:  Nat Rev Neurosci       Date:  2020-04-08       Impact factor: 34.870

2.  Neural Underpinnings of Cortisol Effects on Fear Extinction.

Authors:  Christian Josef Merz; Tanja Christina Hamacher-Dang; Rudolf Stark; Oliver Tobias Wolf; Andrea Hermann
Journal:  Neuropsychopharmacology       Date:  2017-09-26       Impact factor: 7.853

3.  An afferent white matter pathway from the pulvinar to the amygdala facilitates fear recognition.

Authors:  Jessica McFadyen; Jason B Mattingley; Marta I Garrido
Journal:  Elife       Date:  2019-01-16       Impact factor: 8.140

4.  Quantitative EEG Signatures through Amplitude and Phase Modulation Patterns.

Authors:  Mark H Myers; Akaash Padmanabha
Journal:  J Med Signals Sens       Date:  2017 Jul-Sep

5.  Investigating the Subcortical Route to the Amygdala Across Species and in Disordered Fear Responses.

Authors:  Jessica McFadyen
Journal:  J Exp Neurosci       Date:  2019-05-01

6.  Hydrocortisone as an adjunct to brief cognitive-behavioural therapy for specific fear: Endocrine and cognitive biomarkers as predictors of symptom improvement.

Authors:  Susann Steudte-Schmiedgen; Emily Fay; Liliana Capitao; Clemens Kirschbaum; Andrea Reinecke
Journal:  J Psychopharmacol       Date:  2021-04-28       Impact factor: 4.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.